Literature DB >> 6355362

Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.

T Hercend, S Meuer, A Brennan, M A Edson, O Acuto, E L Reinherz, S F Schlossman, J Ritz.   

Abstract

The present studies were carried out to identify surface molecules involved in the cytotoxic effector function of a human natural killer (NK) clone termed JT9. This clone represents a mature T lymphocyte (T3+T8+T11+) mediating NK-like activity. Using JT9 for immunization, one monoclonal antibody termed anti-NKTa was selected that blocked the cytotoxicity of the clone towards K562 cells. Reactivity of anti-NKTa antibody was assessed using a large panel of lymphoid and nonlymphoid cells including a variety of cloned cell lines with either cytotoxic T lymphocyte (CTL) or NK-like activity. Among all cells tested, only two individual clones, JT9 and JT10, were found to express NKTa antigen. JT10 was derived independently from the same individual as JT9 and also represents a mature T cell (T3+T8+T11+) mediating NK-like activity. Like the Ti structure on CTL clones, the molecule defined by anti-NKTa was shown to be membrane associated with T3 in co-modulation experiments. Moreover, anti-NKTa precipitated a 90 kD heterodimeric structure in sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of 125I surface-labeled JT9 cells. The blocking capacity of anti-NKTa was evaluated in cytotoxicity assays using a panel of target cells. The influence of anti-T3 was tested in parallel and it was found that both anti-NKTa and anti-T3 blocked the cytotoxicity of the cloned cells against all targets. Given the potential role of 90 kD molecules as antigen-receptor structures, the specificity of the two NKTa+ NK clones was compared and found superimposable when assessed using 15 in vitro established cell lines. However, in contrast to conventional CTL clones, the expression of cytotoxicity by JT9 and JT10 was not dependent upon recognition of class I or class II major histocompatibility complex gene products on the target cells. In addition, the cytotoxicity of these T8+ NK active clones could not be blocked by anti-T8 antibodies. Taken together, the present data suggest that the specificity of one population of human NK active lymphocytes is determined by clonotypic structures. The NKTa determinant identified here appears to belong to the same family of molecules as Ti structures, previously identified on antigen-specific T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6355362      PMCID: PMC2187119          DOI: 10.1084/jem.158.5.1547

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells.

Authors:  J K Seeley; G Masucci; A Poros; E Klein; S H Golub
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  The functional dissection of human peripheral null cells with respect to antibody-dependent cellular cytotoxicity and natural killing.

Authors:  H Ozer; A J Strelkauskas; R T Callery; S F Schlossman
Journal:  Eur J Immunol       Date:  1979-02       Impact factor: 5.532

5.  Characterization of T cell surface glycoproteins T 1 and T 3 present on all human peripheral T lymphocytes and functionally mature thymocytes.

Authors:  A van Agthoven; C Terhorst; E Reinherz; S Schlossman
Journal:  Eur J Immunol       Date:  1981-01       Impact factor: 5.532

6.  Antibody-dependent cellular cytotoxicity and natural-killer-like activity are mediated by subsets of activated T cells.

Authors:  I J Rimm; S F Schlossman; E L Reinherz
Journal:  Clin Immunol Immunopathol       Date:  1981-10

7.  Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytolytic T lymphocytes (CTL).

Authors:  L D Fast; J A Hansen; W Newman
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

8.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

9.  Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor.

Authors:  S C Meuer; O Acuto; R E Hussey; J C Hodgdon; K A Fitzgerald; S F Schlossman; E L Reinherz
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

10.  Heterogeneity of natural killer cells in the mouse.

Authors:  J A Lust; V Kumar; R C Burton; S P Bartlett; M Bennett
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  29 in total

1.  Functional surface structures on human natural killer cells.

Authors:  R E Schmidt; T Hercend; S F Schlossman; J Ritz
Journal:  Klin Wochenschr       Date:  1985-12-02

Review 2.  Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes.

Authors:  L L Lanier; J H Phillips
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.

Authors:  Y Hansson; M Vargas-Cortes; S Paulie; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Quantitative relationship between T3 and the T-cell antigen receptor on a human leukaemic line.

Authors:  R D Goldin; R A Boulton; A W Boylston
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

5.  Modulation of intestinal immune reactivity by interleukin 2. Phenotypic and functional analysis of lymphokine-activated killer cells from human intestinal mucosa.

Authors:  C Fiocchi; K R Youngman; B Yen-Lieberman; R R Tubbs
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

6.  Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.

Authors:  J P De Villartay; F Le Deist; C Griscelli; A Fischer
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

7.  T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes.

Authors:  J M Leiden; K M Gottesdiener; T Quertermous; L Coury; R A Bray; L Gottschalk; H Gebel; J G Seidman; J L Strominger; A L Landay
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Authors:  T Hercend; J D Griffin; A Bensussan; R E Schmidt; M A Edson; A Brennan; C Murray; J F Daley; S F Schlossman; J Ritz
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

9.  Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.

Authors:  M D Grant; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

10.  Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice.

Authors:  L D Fraker; S A Halter; J T Forbes
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.